Medicine & Life Sciences
HIV
100%
Pharmacokinetics
68%
HIV-1
55%
Ritonavir
51%
Pharmaceutical Preparations
38%
Acquired Immunodeficiency Syndrome
33%
vicriviroc
33%
GSK1265744
29%
efavirenz
28%
Therapeutics
27%
HIV Infections
24%
Drug Interactions
22%
Clinical Trials
22%
Virus Diseases
22%
Safety
21%
Protease Inhibitors
21%
Healthy Volunteers
21%
Reverse Transcriptase Inhibitors
21%
GS-7340
19%
Lopinavir
19%
Nelfinavir
18%
Anti-Retroviral Agents
18%
Rifabutin
17%
Vaccinia virus
17%
Tenofovir
16%
Rilpivirine
16%
Drug Monitoring
16%
Nucleosides
16%
Injections
16%
Antiviral Agents
14%
Viruses
14%
Raltegravir Potassium
13%
Rifampin
13%
RNA
13%
Highly Active Antiretroviral Therapy
13%
Saquinavir
13%
dolutegravir
12%
HIV Protease Inhibitors
12%
Emtricitabine
11%
Confidence Intervals
11%
Darunavir
11%
Human immunodeficiency virus 1 reverse transcriptase
11%
Infections
10%
Indinavir
10%
Didanosine
10%
Panax
10%
Tuberculosis
10%
N'-((1H-benzo(d)imidazol-2-yl)methyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
9%